Experience with Her-2/neu (c-erbB-2) gene status evaluation in breast cancer samples with unusual FISH results

被引:0
|
作者
Trojanec, R. [1 ]
Kolar, Z. [1 ]
Palkova, V. [1 ]
Berkovcova, J. [1 ]
Braunerova, B. [1 ]
Tichy, M. [1 ]
Bouchalova, K. [1 ]
Krejci, V. [1 ]
Melichar, B. [1 ]
Hajduch, M. [1 ]
机构
[1] Palacky Univ, Fac Med, Olomouc, Czech Republic
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:126 / 126
页数:1
相关论文
共 50 条
  • [1] HER-2/neu (c-erbB-2) Expression Assessment in Breast Cancer
    Ioanid, N.
    Anton, E.
    Socolov, Demetra
    GINECO RO, 2009, 5 (01): : 43 - 47
  • [2] HER-2/NEU (C-ERBB-2) GENE STATUS EVALUATION IN THE CZECH NATIONAL REFERENCE CENTRE
    Hajduch, Marian
    Trojanec, Radek
    Spackova, Katerina
    Kolar, Zdenek
    Sedlakova, Eva
    Mlcochova, Sona
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3658 - 3658
  • [3] EXPRESSION OF THE HER-2/NEU/C-ERBB-2 ONCOGENE IN BREAST-CANCER
    PRESS, MF
    GODOLPHIN, W
    SLAMON, DJ
    LABORATORY INVESTIGATION, 1989, 60 (01) : A73 - A73
  • [4] Determination of c-erbB-2 or HER-2/neu as indicator of prognosis in breast cancer
    Müller, L
    Illiger, HJ
    STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (01) : 44 - 46
  • [5] Prognostic and predictive value of c-erbB-2 (HER-2/neu) gene amplification in human breast cancer
    Tsuda H.
    Breast Cancer, 2001, 8 (1) : 38 - 44
  • [6] Evaluation of HER-2/neu (erbB-2) status in breast cancer:: From bench to bedside
    Hanna, W
    Kahn, HJ
    Trudeau, M
    MODERN PATHOLOGY, 1999, 12 (08) : 827 - 834
  • [7] Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the HER-2/neu (c-erbB-2) gene
    Funato, T
    Kozawa, K
    Fujimaki, S
    Miura, T
    Kaku, M
    CHEMOTHERAPY, 2001, 47 (04) : 297 - 303
  • [8] c-erbB-2(HER-2/neu)与乳腺癌
    吴强
    临床与实验病理学杂志, 2005, (01) : 6 - 9
  • [9] AMPLIFICATION OF THE C-ERBB-2(HER-2/NEU) PROTOONCOGENE IN OVARIAN CARCINOMAS
    FAN, QB
    BIAN, ML
    HUANG, SZ
    LANG, JH
    MA, J
    LIU, WS
    XU, XY
    CHINESE MEDICAL JOURNAL, 1994, 107 (08) : 589 - 593
  • [10] CLINICAL AND PATHOLOGICAL SIGNIFICANCE OF THE C-ERBB-2 (HER-2/NEU) ONCOGENE
    SINGLETON, TP
    STRICKLER, JG
    PATHOLOGY ANNUAL, 1992, 27 : 165 - 190